This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Deverra Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Carrie Stoltzman: Innovator in Immunotherapy
Introduction
Carrie Stoltzman is a prominent inventor based in Seattle, WA (US). She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development efforts. With a focus on NK cell compositions, her work aims to enhance therapeutic options for patients.
Latest Patents
Carrie Stoltzman holds a patent for "NK CELL COMPOSITIONS AND PREPARATIONS FOR IMMUNOTHERAPY AND METHODS FOR THEIR PRODUCTION." This patent reflects her dedication to advancing medical science and improving treatment methodologies.
Career Highlights
Stoltzman is currently associated with Deverra Therapeutics Inc., where she continues to push the boundaries of immunotherapy research. Her career is marked by a commitment to developing effective solutions for complex health challenges.
Collaborations
Throughout her career, Carrie has collaborated with notable colleagues, including Mary Prieve and Elizabeth Dam. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Carrie Stoltzman's contributions to immunotherapy exemplify her dedication to advancing medical science. Her innovative work and collaborations position her as a key figure in the field, paving the way for future breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile